Fairchem Organics Dividend 2026 — ₹1/Share, Record Date, Yield & Analysis

How we arrived at the share count

The company's audited results show paid-up equity share capital of ₹1,259.59 Lakhs at a face value of ₹10 per share. Dividing gives 1,25,95,900 shares. Multiplying by ₹1.00 per share gives a total cash outflow of ₹1.26 Crore. Note that share capital fell from ₹1,302.09 Lakhs a year earlier because 4,25,000 shares were extinguished in the January 2026 buyback.

The Board of Directors of Fairchem Organics Limited met on Wednesday, 6 May 2026 through audio-visual means. The meeting began at 12:30 p.m. and ended at 2:50 p.m. Two decisions matter to shareholders.

First, the Board approved the audited financial results for the quarter and financial year ended 31 March 2026. Statutory auditors B S R and Co, Chartered Accountants, issued an unmodified opinion — meaning no qualifications, reservations, or adverse findings were raised.

Second, the Board recommended a dividend of 10%, i.e. ₹1.00 per equity share on a face value of ₹10, subject to shareholder approval at the ensuing 7th AGM.

Announcement, record date and book closure dates are from the company's filing of 6 May 2026. The expected payment date of 26 August 2026 is reported by market data providers and is not stated in the board meeting outcome filing itself; shareholders should treat it as indicative until the company confirms.

Why the ex-date and record date are the same

Older articles will tell you the ex-date is "two business days before the record date". That guidance is outdated. Since Indian equities moved to a T+1 settlement cycle, a trade settles the very next working day. The exchanges therefore now set the ex-date on the same day as the record date. To have received this dividend, you needed to buy the share on or before 17 July 2026 (the last trading day before 20 July).

Dividend Track Record Since Listing

The FY24 and FY25 figures of ₹7.50 are corroborated by the audited cash flow statement, which shows "Dividend Paid" of ₹976.57 Lakhs in both FY26 and FY25. Against roughly 1.30 Crore shares that works out to ₹7.50 per share in each year. Fairchem Organics listed only in 2020-21 following the demerger from Fairchem Speciality Limited, so a full ten-year dividend record does not exist.

FY2025-26 Audited Results (Standalone)

All figures converted from the company's reported ₹ Lakhs to ₹ Crore. EBITDA is derived as Profit Before Tax + Finance Costs + Depreciation and Amortisation, and is a ShareBazaar Online computation, not a company-disclosed figure. Fairchem Organics has no subsidiary, associate or joint venture as on 31 March 2026, so standalone results are the consolidated position.

Operating Leverage: revenue fell 14.5%, profit fell 74.8%

This is the defining feature of the year. Revenue declined by roughly one-seventh. Net profit declined by three-quarters. The gap between those two numbers is negative operating leverage — the company's cost base did not shrink as fast as its sales.

The line-by-line breakdown explains exactly why:

Two cost lines rose while revenue fell 14.5%: depreciation, up 4.6%, and finance costs, up 0.8%. These are fixed charges tied to the asset base and the borrowings, and they do not flex with sales. Depreciation and interest together consumed ₹14.72 Crore — nearly 2.7 times the entire year's net profit of ₹5.54 Crore.

Cost of materials fell 10.9% against a 14.5% revenue decline. Because raw material cost did not fall as fast as sales, gross margin compressed. In an oleo-chemicals business built on processing by-products of edible-oil refining, this is the classic signature of a spread squeeze: input prices held up while realisations weakened.

Audited Cash Flow Statement

How is this dividend being funded?

The dividend is comfortably funded by current-year free cash flow, not by borrowings or asset sales. On an FCF basis the coverage is exceptional.

However — and this is a finding worth flagging prominently — the company's balance-sheet cash is only ₹1.23 Crore, which is less than the ₹1.26 Crore dividend itself. Fairchem Organics runs a near-zero-cash treasury and funds working capital through ₹83.78 Crore of short-term borrowings. There is no cash reserve buffer here. Every rupee of dividend must be generated fresh from operations or drawn from the credit line.

Coverage Metrics

Verdict: Sustainable — but only because it was cut to a token level

ShareBazaar Online classifies this dividend as Sustainable. That classification needs an honest caveat attached to it.

A ₹1.26 Crore outflow against ₹41.60 Crore of operating cash flow is trivially affordable. The payout ratio of 22.7% is conservative. Coverage on every measure except balance-sheet cash is strong.

But consider the counterfactual. Had the Board maintained ₹7.50 per share, the outflow would have been ₹9.45 Crore against a net profit of ₹5.54 Crore — a payout ratio of 171%. The company would have been paying out substantially more than it earned, in a year when borrowings were already rising. The dividend is sustainable precisely because it was cut.

Read that way, the cut is arguably a sign of financial discipline rather than distress — a board choosing balance-sheet preservation over optics. Income investors, however, do not get to bank discipline. They get ₹1.00.

Speciality Chemicals — Dividend Yield Benchmark

Laxmi Organic and sector-average figures sourced from TipRanks dividend data as at the FY25 payout cycle. FY25 Fairchem payout ratio computed as ₹9.77 Cr dividend ÷ ₹21.97 Cr PAT. Peer set is limited: Fairchem Organics is a single-segment small-cap oleochemicals manufacturer with few directly comparable listed peers of similar size and product mix.

The alignment question

One useful test of a dividend cut is whether the controlling shareholder shares the pain. Here, they clearly do. The Fairfax-linked promoter group holds 63.25% and therefore absorbs 63.25% of the ₹8.19 Crore reduction in total dividend versus last year — roughly ₹5.18 Crore of forgone income.

There is no structure here where the promoter extracts cash while minority holders are diluted. The promoter is the largest single loser from the cut in absolute rupee terms. That is a meaningfully different situation from a company maintaining a high dividend to service promoter obligations while the underlying business deteriorates.

It is also worth noting that zero promoter shares are pledged, removing one common source of pressure to maintain artificial payouts.

Where FY26 capital actually went

How dividends are taxed in India

Since the abolition of Dividend Distribution Tax in Budget 2020, dividends are taxed entirely in the hands of the shareholder. The company no longer pays tax on your behalf.

• Dividend income is taxed under the head "Income from Other Sources".
• It is added to your total income and taxed at your applicable slab rate, plus applicable surcharge and 4% health and education cess.
• The company deducts TDS at 10% under Section 194 if total dividend paid to a resident shareholder in a financial year exceeds the prescribed threshold. Following Budget 2025, that threshold was raised to ₹10,000 per company per financial year with effect from FY 2025-26.
• If PAN is not furnished, TDS is deducted at 20%.
• Shareholders with income below the taxable limit may file Form 15G (or Form 15H for senior citizens) to avoid TDS.
• TDS is only an advance collection — the final liability is settled at your slab rate when you file your return, and excess TDS is refundable.
• A deduction is available for interest expense incurred to earn dividend income, capped at 20% of the dividend.
• Non-resident shareholders are generally subject to 20% TDS plus surcharge and cess, subject to relief under the applicable Double Taxation Avoidance Agreement.

Tax rules change with each Finance Act. Shareholders should confirm current thresholds and rates with a qualified tax professional before acting.

• Q1 FY27 EBITDA margin. Q4 FY26 EBITDA margin recovered to about 6.9% from 4.2% in Q3. If Q1 FY27 holds above 6.5%, the margin turn is real. If it slips back toward 4%, FY26's Q4 was a one-off. This is the single highest-signal number to watch.
• Cost of materials as a percentage of revenue. FY26 ran at 81.4%. Watch whether this falls back below 80% as isostearic acid and other value-added products scale. This ratio, more than any other, determines whether Fairchem earns anything.
• Short-term borrowings at each quarter-end. The number rose from ₹63.03 Cr to ₹83.78 Cr in FY26. A continued climb while profits stay depressed would be the clearest warning sign on the balance sheet.
• Trade receivable days. Receivables fell ₹18.07 Cr in FY26 after rising ₹29.27 Cr in FY25. This line has whipsawed. Consistent, disciplined collections would confirm the FY26 cash improvement is structural rather than a one-year correction.
• Capital work-in-progress and capex run-rate. CWIP rose to ₹18.38 Cr while capex fell to ₹15.34 Cr. Watch whether CWIP converts into commissioned capacity, and whether capex reaccelerates in line with the FY30 revenue ambition.
• Export mix and isostearic acid ramp. Management has flagged export strategy and value-added products as growth levers. Track disclosed export share and volume commentary in quarterly investor presentations and earnings calls.
• Further Labour Code provisioning. The company has said additional accounting effects will follow as rules are notified. Any incremental provision should be read against the small FY26 profit base.
• FY27 dividend recommendation (expected May 2027). Whether the Board restores a meaningful payout, holds at ₹1.00, or moves again will reveal how it now thinks about capital return versus balance-sheet repair.
• Promoter and FII holding trend. Promoter holding is 63.25% post-buyback with zero pledge. Watch quarterly shareholding filings for any change in the Fairfax-linked group's stance or in the 6.34% FII position.
• CARE Ratings actions. Ratings were reaffirmed at CARE A / A1 in June 2026 on facilities of ₹173.99 Crore. Any outlook change would be an early, independent signal on financial health.

Fairchem Organics Limited's FY26 dividend of ₹1.00 per share is, in isolation, an unremarkable corporate action worth ₹1.26 Crore. Read against the ₹7.50 paid in each of the previous two years, it is one of the sharpest single-year dividend reductions among listed Indian speciality chemicals companies this cycle — a cut of 86.7%.

The cut follows a year in which revenue fell 14.5% and net profit fell 74.8% to ₹5.54 Crore. Fixed costs — depreciation and interest — did not flex with sales and together consumed 2.7 times the year's entire profit.

The most useful way to frame this: the dividend cut is the symptom, not the story. The story is a single-segment chemicals business with a squeezed spread, rising fixed charges, near-zero treasury cash, and a management team targeting ₹2,000 Crore of revenue by FY30 from a ₹460 Crore base. The Board's decision to preserve ₹8.19 Crore of cash rather than pay out 171% of profit is defensible on its own terms. Whether the business can rebuild the earnings power that once supported a ₹7.50 dividend is a question FY27 will answer, not this announcement.

ShareBazaar Online does not issue buy, sell or hold recommendations. The figures, computations, risks and monitoring factors above are presented so readers can reach their own conclusions.

This article is published by ShareBazaar Online for informational and educational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security. ShareBazaar Online does not issue buy, sell or hold recommendations.

All company-disclosed figures are sourced from Fairchem Organics Limited's Outcome of Board Meeting filing dated 6 May 2026, together with the audited financial results, audited statement of assets and liabilities, and audited cash flow statement for the year ended 31 March 2026, as submitted to NSE and BSE. Market prices, shareholding data, dividend history for prior years, peer comparisons and the expected payment date are sourced from third-party market data providers and exchange disclosures, and are indicated as such in the text. All derived ratios — EBITDA, ROE, ROCE, free cash flow, coverage ratios and payout ratios — are ShareBazaar Online computations and are not company-disclosed figures.

Market prices change continuously; yield figures calculated in this article will move with the share price. The dividend described is a Board recommendation and remains subject to shareholder approval at the AGM on 27 July 2026. Tax rules referenced are subject to amendment by each Finance Act.

Securities markets are subject to market risks. Please read all related documents carefully before investing. Investors should consult a SEBI-registered investment adviser and a qualified tax professional before making any investment or tax decision. ShareBazaar Online and its authors accept no liability for any loss arising from the use of this information.